PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1993 | 1 |
| 1998 | 1 |
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 5 |
| 2004 | 4 |
| 2005 | 13 |
| 2006 | 16 |
| 2007 | 29 |
| 2008 | 249 |
| 2009 | 215 |
| 2010 | 197 |
| 2011 | 216 |
| 2012 | 172 |
| 2013 | 270 |
| 2014 | 426 |
| 2015 | 399 |
| 2016 | 308 |
| 2017 | 329 |
| 2018 | 260 |
| 2019 | 284 |
| 2020 | 323 |
| 2021 | 328 |
| 2022 | 268 |
| 2023 | 229 |
| 2024 | 298 |
| 2025 | 374 |
| 2026 | 163 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"J Am Soc Nephrol"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Executive Summary of the ASN Kidney Health Guidance on the Cardiovascular‑Kidney‑Metabolic Syndrome.
- Navaneethan SD, Rifkin B, Mottl AK; on behalf of the ASN Kidney Health Workgroup on the Cardiovascular-Kidney-Metabolic Syndrome.
- J Am Soc Nephrol. 2026 Sep 2;37(10):2278-2281. doi: 10.1681/ASN.0000001230.
- PMCID: PMC13641457
Navaneethan SD, et al.J Am Soc Nephrol. 2026.PMCID: PMC13641457 -
ASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic Syndrome.
- Bansal N, Bjornstad P, Bress AP, Chang TI, Cheng X, Estrella MM, Go AS, Mottl AK, Navaneethan SD, Neuen BL, Rifkin BS, Zuber K, Chang AR; on behalf of the ASN Kidney Health Guidance Workgroup on the Cardiovascular-Kidney-Metabolic Syndrome.
- J Am Soc Nephrol. 2026 Sep 2;37(10):2282-2305. doi: 10.1681/ASN.0000001231.
- PMCID: PMC13641481
Bansal N, et al.J Am Soc Nephrol. 2026.PMCID: PMC13641481 -
Dismissing the Chaperone in the Diabetic Kidney.
- Mallipattu SK.
- J Am Soc Nephrol. 2026 Aug 27;37(10):2091-2093. doi: 10.1681/ASN.0000001237.
- PMCID: PMC13641441
Mallipattu SK.J Am Soc Nephrol. 2026.PMCID: PMC13641441 -
Authors' Reply: Normalization Benchmarking for nCounter Diagnostics Requires Deployment- and Biology-Aware Evaluation.
- Piedrafita A, Sablik M, Loupy A.
- J Am Soc Nephrol. 2026 Aug 24;37(10):2348-2349. doi: 10.1681/ASN.0000001234.
- PMCID: PMC13641469
Piedrafita A, et al.J Am Soc Nephrol. 2026.PMCID: PMC13641469 -
Normalization Benchmarking for nCounter Diagnostics Requires Deployment- and Biology-Aware Evaluation.
- Zielinski D.
- J Am Soc Nephrol. 2026 Aug 24;37(10):2346-2347. doi: 10.1681/ASN.0000001206.
- PMCID: PMC13641534
Zielinski D.J Am Soc Nephrol. 2026.PMCID: PMC13641534 -
Interpreting Donor-Derived Cell-Free DNA: From Performance to Decision.
- Meudec A, Aubert O.
- J Am Soc Nephrol. 2026 Aug 21;37(10):2100-2102. doi: 10.1681/ASN.0000001240.
- PMCID: PMC13641529
Meudec A, et al.J Am Soc Nephrol. 2026.PMCID: PMC13641529 -
Maternal Health and Kidney Function in Offspring.
- Nakum C, Schuh MP.
- J Am Soc Nephrol. 2026 Aug 19;37(10):2088-2090. doi: 10.1681/ASN.0000001214.
- PMCID: PMC13641504
Nakum C, et al.J Am Soc Nephrol. 2026.PMCID: PMC13641504 -
Medication Effects on Cystatin C and the Interpretation of Kidney Function: Imperfect but Informative.
- Barreto EF, Williams VL.
- J Am Soc Nephrol. 2026 Aug 18;37(10):2094-2096. doi: 10.1681/ASN.0000001229.
- PMCID: PMC13641453
Barreto EF, et al.J Am Soc Nephrol. 2026.PMCID: PMC13641453 -
Dual B -Cell Maturation Antigen/CD19 Chimeric Antigen Receptor- T Therapy for AL Amyloidosis : Targeting the Clone, Saving the Kidney.
- Sobczak K, Leick MB.
- J Am Soc Nephrol. 2026 Aug 18;37(10):2097-2099. doi: 10.1681/ASN.0000001223.
- PMCID: PMC13641489
Sobczak K, et al.J Am Soc Nephrol. 2026.PMCID: PMC13641489 -
Angiopoietin-2 and Progressive Kidney Disease.
- Jeansson M.
- J Am Soc Nephrol. 2026 Aug 11;37(10):2085-2087. doi: 10.1681/ASN.0000001207.
- PMCID: PMC13641532
Jeansson M.J Am Soc Nephrol. 2026.PMCID: PMC13641532